South Africa suspends Johnson & Johnson vaccine rollout over blood clot concerns
Earlier Federal health agencies on Tuesday called for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination.
April 13, 2021 / 10:58 PM IST
Johnson & Johnson. | Representative Image (PC-Reuters)
South Africa on Tuesday suspended the rollout of the Johnson & Johnson Covid-19 vaccine over potential blood clot risks reported by the United States, the health minister said.
US Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases
"We have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson & Johnson vaccine is sufficiently interrogated," Health Minister Zweli Mkhize announced in an online press briefing.